NO20074880L - Proteaseinhibitor forloper syntese - Google Patents

Proteaseinhibitor forloper syntese

Info

Publication number
NO20074880L
NO20074880L NO20074880A NO20074880A NO20074880L NO 20074880 L NO20074880 L NO 20074880L NO 20074880 A NO20074880 A NO 20074880A NO 20074880 A NO20074880 A NO 20074880A NO 20074880 L NO20074880 L NO 20074880L
Authority
NO
Norway
Prior art keywords
synthesis
protease inhibitor
proceeds
inhibitor proceeds
processes
Prior art date
Application number
NO20074880A
Other languages
English (en)
Norwegian (no)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20074880L publication Critical patent/NO20074880L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Peptides Or Proteins (AREA)
NO20074880A 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese NO20074880L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (fr) 2005-02-25 2006-02-24 Synthese de precurseur d'inhibiteur de la protease

Publications (1)

Publication Number Publication Date
NO20074880L true NO20074880L (no) 2007-09-25

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074880A NO20074880L (no) 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese

Country Status (19)

Country Link
US (2) US8067463B2 (fr)
EP (1) EP1856125B1 (fr)
JP (1) JP5260965B2 (fr)
KR (1) KR101333627B1 (fr)
CN (1) CN101128469B (fr)
AT (1) ATE440848T1 (fr)
AU (1) AU2006217922B2 (fr)
BR (1) BRPI0607827B8 (fr)
CA (1) CA2595295C (fr)
DE (1) DE602006008751D1 (fr)
DK (1) DK1856125T3 (fr)
ES (1) ES2331257T3 (fr)
IL (1) IL184519A (fr)
MX (1) MX2007010378A (fr)
NO (1) NO20074880L (fr)
PL (1) PL1856125T3 (fr)
PT (1) PT1856125E (fr)
RU (1) RU2421459C2 (fr)
WO (1) WO2006089942A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
WO2012075122A2 (fr) * 2010-11-30 2012-06-07 Purdue Research Foundation Procédés et intermédiaires pour la préparation d'hexahydrofuro[2,3-b]furannes substitués
CN116102569B (zh) * 2021-11-11 2025-02-18 深圳容金科技有限公司 一种展青霉素半抗原的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2872424C (fr) 1998-06-23 2017-03-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derives de bisfurane utiles dans la prevention de l'emergence de souches de vih multiresistantes aux medicaments et le traitement du vih
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
EP1089328A1 (fr) 1999-09-29 2001-04-04 Infineon Technologies AG Méthode de formation d'un dispositif semiconducteur
PL204924B1 (pl) 1999-10-06 2010-02-26 Tibotec Pharm Ltd Heksahydrofuro [2,3-b] furanylo-3-N-{3(1,3-benzodioksolilo-5-sulfonylo) (izobutylo) amino] -1-benzylo-2-hydroksypropylo} karbaminian oraz jego zastosowanie
US7659404B2 (en) 2001-02-14 2010-02-09 Tibotec Pharmaceuticals Ltd. Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
OA12464A (en) 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
WO2002092595A1 (fr) 2001-05-11 2002-11-21 Tibotec Pharmaceuticals Ltd. Inhibiteurs des proteases du vih a large spectre sous forme de 2-amino-benzoxazole sulfonamides
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
MY138657A (en) 2001-12-21 2009-07-31 Tibotec Pharm Ltd broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
AU2003202914A1 (en) 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US20050158709A1 (en) 2002-02-22 2005-07-21 Hilde Azijn Methods for determinging the influence of protein binding on antiretroviral activity
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
WO2003091264A2 (fr) 2002-04-26 2003-11-06 Gilead Sciences, Inc. Inhibiteurs non nucleosidiques de la transcriptase inverse
BRPI0311176B8 (pt) 2002-05-16 2021-05-25 Janssen Sciences Ireland Uc pseudopolimorfo na forma de etanolato, seu uso, processo de preparação do mesmo e composição farmacêutica
IL165043A0 (en) 2002-05-17 2005-12-18 Tibotec Pharm Ltd broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
EP1520247B1 (fr) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Profils mutationnels dans une protease du vih-1 correles a une resistance phenotypique aux medicaments

Also Published As

Publication number Publication date
PL1856125T3 (pl) 2010-01-29
JP2008531522A (ja) 2008-08-14
US20120041215A1 (en) 2012-02-16
IL184519A0 (en) 2007-10-31
CN101128469B (zh) 2012-11-14
AU2006217922A1 (en) 2006-08-31
CN101128469A (zh) 2008-02-20
ATE440848T1 (de) 2009-09-15
US8067463B2 (en) 2011-11-29
IL184519A (en) 2012-01-31
CA2595295C (fr) 2014-07-08
RU2421459C2 (ru) 2011-06-20
KR20080005183A (ko) 2008-01-10
PT1856125E (pt) 2009-11-06
KR101333627B1 (ko) 2013-11-27
RU2007135345A (ru) 2009-03-27
MX2007010378A (es) 2007-09-25
JP5260965B2 (ja) 2013-08-14
ES2331257T3 (es) 2009-12-28
EP1856125B1 (fr) 2009-08-26
DK1856125T3 (da) 2009-12-07
CA2595295A1 (fr) 2006-08-31
BRPI0607827B8 (pt) 2021-05-25
US8183394B2 (en) 2012-05-22
US20090054668A1 (en) 2009-02-26
EP1856125A1 (fr) 2007-11-21
BRPI0607827B1 (pt) 2019-11-05
WO2006089942A1 (fr) 2006-08-31
BRPI0607827A2 (pt) 2009-10-06
DE602006008751D1 (de) 2009-10-08
WO2006089942A8 (fr) 2007-12-13
AU2006217922B2 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
TW200616646A (en) Synthesis of boronic ester and acid compounds
ATE453670T1 (de) Acrylierte hyaluronsäure
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
UA102220C2 (ru) Способ синтеза агомелатина
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
MX2012003488A (es) Proceso para la elaboracion de n-acil-bifenil-alanina.
DK1480491T3 (da) Tynd højttaler samt fremgangsmåde til fremstilling deraf
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
DE502006005053D1 (de) Spritzbare akustikmassen
NO20074880L (no) Proteaseinhibitor forloper syntese
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo
ATE429417T1 (de) Hiv-protease-inhibitoren
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
BRPI0607390A2 (pt) Processo para recuperar cci-779 de licores mâe
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
ATE464280T1 (de) Synthese von idarubin-aglycon
ITAN20040029A1 (it) Processo per la produzione di un elemento angolare per mobili

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: JANSSEN SCIENCES IRELAND UC, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application